NCT07587346 The Impact of Whole-Body Vibration and Relaxation Techniques on Adolescent Athlete Girls With Triad Syndrome"
| NCT ID | NCT07587346 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MTI University |
| Condition | Menstrual Cycle Abnormal |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-11-02 |
| Primary Completion | 2026-01-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-11-02 with a primary completion date of 2026-01-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to explore the effects of Whole-Body Vibration (WBV) exercises and relaxation techniques on adolescent female athletes who are experiencing Female Athlete Triad Syndrome - a condition that may include low bone density, irregular menstrual cycles, and low energy availability. Participants will take part in a structured program combining vibration training and relaxation sessions over several weeks. The goal is to determine whether this combination can improve bone health, menstrual regularity, physical performance, and overall well-being in young female athletes.
Eligibility Criteria
Inclusion Criteria: * Low energy availability (with or without disordered eating) * Menstrual dysfunction (oligomenorrhea) * Low bone mineral density or a history of stress fractures Exclusion criteria: * Recent fractures or unhealed stress fractures within the last 6 months. * Presence of serious medical conditions that contraindicate WBV or exercise participation, such as: Uncontrolled cardiovascular disease, Uncontrolled hypertension, Neurological disorders, Severe vestibular disorders, Active cancer, Bleeding/clotting disorders. * Severe eating disorder requiring inpatient medical or psychiatric treatment. * Current use of medications that significantly affect bone or hormonal status * Participation in another interventional clinical study within the last 3 months. * Inability or unwillingness to provide assent/consent or comply with study procedures.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07587346 clinical trial?
This trial is open to female participants only, aged 14 Years or older, up to 16 Years, studying Menstrual Cycle Abnormal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07587346 currently recruiting?
Yes, NCT07587346 is actively recruiting participants. Contact the research team at shaimaa.mohamed@pt.mti.edu.eg for enrollment information.
Where is the NCT07587346 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07587346 clinical trial?
NCT07587346 is sponsored by MTI University. The trial plans to enroll 50 participants.